主要组织相容性复杂I类匹配是必要的,但不足以在捐赠血液细胞移植后诱导对血管化复合异体移植的耐受性
Elin Manell1,2, M Esad Gunes1, Sarah Merl3
1Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.
Transplantation direct
|January 14, 2026
概括
主体组织相容性复合体 (MHC) 类I匹配对于成功的血管化复合体全移植 (VCA) 移植与血液细胞移植 (HCT) 移植至关重要. 一类匹配确保了移植的接受,而二类匹配影响了耐受性结果.
科学领域:
- 移植免疫学 移植免疫学
- 免疫遗传学 免疫遗传学
- 移植拒绝机制 移植拒绝机制
背景情况:
- 之前的研究已经建立了一个用于血管化复合性全体移植 (VCA) 和血液细胞移植 (HCT) 的猪模型.
- 耐受性与主要体内相容性复合体 (MHC) 类I匹配而没有类II匹配,但不是反之.
- 目前的研究调查了MHC类I和类II不匹配是否有助于移植拒绝.
研究的目的:
- 确定MHC I类和II类匹配在VCA移植耐受性中的作用.
- 在并发HCT的背景下,研究MHC类I和类II匹配之间的相互作用.
主要方法:
- 猪在单个MHC I类单双原型中不匹配或在单个II类单双原型中匹配.
- 接收猪接受了CD3免疫毒素,全身照射,然后进行HCT和VCA移植.
- 循环氨酸免疫抑制在45天后被撤回.
主要成果:
- 有单个MHC类I不匹配的猪保持了奇默症并接受了VCA移植,除了一个例外 (表皮排斥).
- 匹配单个MHCII类哈普洛型的猪丢失了骨髓移植和拒绝了VCA移植.
- 这些发现表明MHC类I和II匹配在移植耐受性中的不同作用.
结论:
- 在HCT/VCA移植中诱导耐受性至关重要.
- 当I类部分匹配时,MHCII类匹配的程度会调整耐受性结果.
- 完整的MHC I类匹配保证了VCA的耐受性,无论II类匹配状态如何.
相关概念视频
Tissue Transplantation
894
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
894
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876


